Cargando…

Flower-like Composite Material Delivery of Co-Packaged Lenvatinib and Bufalin Prevents the Migration and Invasion of Cholangiocarcinoma

The co-delivery of multiple drugs using nanocarriers has been recognized as a promising strategy for cancer treatment to enhance therapeutic efficacy. In this study, a monodisperse mesoporous silica nanoparticle (mSiO(2)) is prepared and functionalized into high-efficiency loaded Lenvatinib and Bufa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Zhouyu, Zhao, Yingke, Yan, Xia, Hua, Yongqiang, Meng, Zhiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230555/ https://www.ncbi.nlm.nih.gov/pubmed/35745387 http://dx.doi.org/10.3390/nano12122048

Ejemplares similares

Lenvatinib inhibits intrahepatic cholangiocarcinoma via Gadd45a-mediated cell cycle arrest
por: Yan, Xia, et al.
Publicado: (2023)

Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling
por: Wang, Haiyong, et al.
Publicado: (2016)

Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway
por: Wang, Haiyong, et al.
Publicado: (2016)

High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cells
por: Ning, Zhouyu, et al.
Publicado: (2019)

Bufalin Suppresses Migration and Invasion of Hepatocellular Carcinoma Cells Elicited by Poly (I:C) Therapy
por: Feng, Yinglu, et al.
Publicado: (2018)

Synergistic anticancer effects of bufalin and sorafenib by regulating apoptosis associated proteins
por: Wang, Haiyong, et al.
Publicado: (2018)

Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma
por: Zhang, Chenyue, et al.
Publicado: (2017)

Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells
por: Qiu, Dong-Ze, et al.
Publicado: (2013)

A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib
por: Osuga, Takahiro, et al.
Publicado: (2022)

M2 macrophage inhibits the antitumor effects of Lenvatinib on intrahepatic cholangiocarcinoma
por: Yang, Long, et al.
Publicado: (2023)

Enhanced Intestinal Permeability of Bufalin by a Novel Bufalin-Peptide-Dendrimer Inclusion through Caco-2 Cell Monolayer
por: Chan, Chi-on, et al.
Publicado: (2017)

Anti-Inflammatory and Antinociceptive Activities of Bufalin in Rodents
por: Wen, Lili, et al.
Publicado: (2014)

Synthesis and Biological Evaluation of Novel Bufalin Derivatives
por: Sampath, VishnuPriya, et al.
Publicado: (2022)

The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma
por: Jiang, Han-yu, et al.
Publicado: (2022)

Metformin Inhibits Migration and Invasion of Cholangiocarcinoma Cells
por: Son, Trinh Xuan, et al.
Publicado: (2017)

Prognostic nutritional index serves as a predictive marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma
por: Zhang, Chenyue, et al.
Publicado: (2016)

Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression
por: Wang, Jie, et al.
Publicado: (2018)

Assessment of migration regularity of phthalates from food packaging materials
por: Liu, Jing‐Min, et al.
Publicado: (2020)

Bufalin Induces Glioma Cell Death by Apoptosis or Necroptosis
por: LingHu, Hai Rui, et al.
Publicado: (2020)

Lenvatinib Combined With a PD-1 Inhibitor as Effective Therapy for Advanced Intrahepatic Cholangiocarcinoma
por: Xie, Lulu, et al.
Publicado: (2022)

A case of toxic epidermal necrolysis associated with lenvatinib and sintilimab therapy for intrahepatic cholangiocarcinoma
por: Gong, Yinhua, et al.
Publicado: (2023)

Single-cell transcriptome analysis revealed the immune profile of PD-1 blockade in gallbladder carcinoma liver metastasis
por: Xie, Lin, et al.
Publicado: (2023)

Systemic Sequential Therapy of CisGem, Tislelizumab, and Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma Conversion Therapy
por: Ding, Yuan, et al.
Publicado: (2021)

Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
por: Yuan, Jiani, et al.
Publicado: (2017)

The Mechanism of Bufalin-Induced Apoptosis of K562/A02
por: Xie, Ying, et al.
Publicado: (2019)

ZHX1 Promotes the Proliferation, Migration and Invasion of Cholangiocarcinoma Cells
por: Kwon, Ryuk-Jun, et al.
Publicado: (2016)

A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice
por: Liu, Miao, et al.
Publicado: (2016)

Immunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanoma
por: Li, Ying, et al.
Publicado: (2014)

Hepatic arterial infusion chemotherapy with or without lenvatinib for unresectable cholangiocarcinoma: a single-center retrospective study
por: Wang, Yajing, et al.
Publicado: (2023)

Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice
por: Zhang, Zhou-Ji, et al.
Publicado: (2014)

Bufalin sensitizes human bladder carcinoma cells to TRAIL-mediated apoptosis
por: Kang, Kyung-Hwa, et al.
Publicado: (2017)

Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer
por: Yuan, Ze-Ting, et al.
Publicado: (2017)

Bufalin suppresses ovarian cancer cell proliferation via EGFR pathway
por: Dou, Lei, et al.
Publicado: (2022)

Bufalin reverses ABCB1-mediated resistance to docetaxel in breast cancer
por: Zhang, Die, et al.
Publicado: (2023)

New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
por: Cheng, Chien-shan, et al.
Publicado: (2019)

Biopolymer Composites as an Alternative to Materials for the Production of Ecological Packaging
por: Prochon, Miroslawa, et al.
Publicado: (2021)

Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo
por: Liu, Tao, et al.
Publicado: (2016)

Packaging biological cargoes in mesoporous materials: opportunities for drug delivery
por: Siefker, Justin, et al.
Publicado: (2014)

Sintilimab Combined with Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma in Second-Line Setting—A Multi-Center Observational Study
por: Ding, Xiaoyan, et al.
Publicado: (2022)

Radiosynthesis and pharmacokinetics of [(18)F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice
por: Yang, Zhaoshuo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0tij9h0eevttb211crg7j777s4